Cargando…

The 5th Canadian Symposium on Hepatitis C Virus: We Are Not Done Yet—Remaining Challenges in Hepatitis C

Hepatitis C virus (HCV) affects approximately 268,000 Canadians and results in more years of life lost than any other infectious disease in the country. Both the Canadian Institutes of Health Research (CIHR) and the Public Health Agency of Canada (PHAC) have identified HCV-related liver disease as a...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Buuren, Nicholas, Fradette, Lorraine, Grebely, Jason, King, Alexandra, Krajden, Mel, MacParland, Sonya A., Marshall, Alison, Saeed, Sahar, Wilson, Joyce, Klein, Marina B., Sagan, Selena M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5098058/ https://www.ncbi.nlm.nih.gov/pubmed/27843889 http://dx.doi.org/10.1155/2016/7603526

Ejemplares similares

Highlights of the Fourth Canadian Symposium on Hepatitis C: Moving towards a National Action Plan
por: Sagan, Selena M., et al.
Publicado: (2016)

Patient-derived hepatitis C virus inhibits CD4(+) but not CD8(+) T lymphocyte proliferation in primary T cells
por: MacParland, Sonya A., et al.
Publicado: (2015)

Declining Incidence of Hepatitis C Virus Infection among People Who Inject Drugs in a Canadian Setting, 1996-2012
por: Grebely, Jason, et al.
Publicado: (2014)

The Population Level Cascade of Care for Hepatitis C in British Columbia, Canada: The BC Hepatitis Testers Cohort (BC-HTC)
por: Janjua, Naveed Z., et al.
Publicado: (2016)

Poly(rC)-Binding Protein 1 Limits Hepatitis C Virus Virion Assembly and Secretion
por: Cousineau, Sophie E., et al.
Publicado: (2022)

Assessment of Treatment Strategies to Achieve Hepatitis C Elimination in Canada Using a Validated Model
por: Binka, Mawuena, et al.
Publicado: (2020)

Paediatric HIV: we are not done yet!
por: Penazzato, Martina
Publicado: (2020)

Mortality among British Columbians testing for hepatitis C antibody
por: Yu, Amanda, et al.
Publicado: (2013)

Twin epidemics of new and prevalent hepatitis C infections in Canada: BC Hepatitis Testers Cohort
por: Janjua, Naveed Zafar, et al.
Publicado: (2016)

Interferon-λ Genetic Variations and Hepatitis C: Yet to be Discovered
por: Keshvari, Maryam, et al.
Publicado: (2014)

Immunological Determinants of Liver Transplant Outcomes Uncovered by the Rat Model
por: Wang, Xinle, et al.
Publicado: (2021)

Chronic hepatitis C infection is associated with higher incidence of extrahepatic cancers in a Canadian population based cohort
por: Darvishian, Maryam, et al.
Publicado: (2022)

Hepatitis C cross-genotype immunity and implications for vaccine development
por: Islam, Nazrul, et al.
Publicado: (2017)

Membrane Physiology and Biophysics—What Remains to Be Done?
por: Fahlke, Christoph
Publicado: (2020)

P232 MOLECULAR PHYLOGENETICS OF HEPATITIS C VIRUS (HCV) AS A TOOL TO UNDERSTAND THE HCV EPIDEMIC IN BRITISH COLUMBIA (BC), CANADA
por: Olmstead, A., et al.
Publicado: (2014)

Enhancement of hepatitis C viral RNA abundance by precursor miR-122 molecules
por: Cox, Erica Machlin, et al.
Publicado: (2013)

Sequencing of the Hepatitis C Virus: A Systematic Review
por: Jacka, Brendan, et al.
Publicado: (2013)

Global elimination of hepatitis C virus infection: Progresses and the remaining challenges
por: Taherkhani, Reza, et al.
Publicado: (2017)

Acute hepatitis C virus infection: clinical update and remaining challenges
por: Liu, Chen-Hua, et al.
Publicado: (2023)

Restoration of HCV-Specific Immune Responses with Antiviral Therapy: A Case for DAA Treatment in Acute HCV Infection
por: Casey, Julia L., et al.
Publicado: (2019)

Timely Hepatitis C RNA Testing and Treatment in the Era of Direct-Acting Antiviral Therapy among People with Hepatitis C in New South Wales, Australia
por: Yousafzai, Mohammad T., et al.
Publicado: (2022)

There’s Much Yet to be Done: Diverse Perspectives on HPV Vaccination
por: Zimet, Gregory D., et al.
Publicado: (2019)

Influence of lipid-lowering drugs on inflammation: what is yet to be done?
por: Ugovšek, Sabina, et al.
Publicado: (2021)

Transmission genetics of drug-resistant hepatitis C virus
por: van Buuren, Nicholas, et al.
Publicado: (2018)

Seroprevalences of hepatitis B virus and hepatitis C virus among participants of an Asian health fair in the Lower Mainland, British Columbia
por: Ip, Stephen, et al.
Publicado: (2015)

Hepatitis B and C in Pregnancy and Children: A Canadian Perspective
por: Mendlowitz, Andrew B., et al.
Publicado: (2022)

Amantadine for chronic hepatitis C: a magic bullet or yet another dead duck?
por: Craxì, Antonio, et al.
Publicado: (2001)

Cystic Fibrosis: A Disease in Transformation, yet More Work to Be Done!
por: Ramsey, Bonnie W., et al.
Publicado: (2022)

Transcriptional profiling of the effects of 25-hydroxycholesterol on human hepatocyte metabolism and the antiviral state it conveys against the hepatitis C virus
por: Pezacki, John Paul, et al.
Publicado: (2009)

A Hepatitis C Educational Needs Assessment of Canadian Healthcare Providers
por: Naghdi, Reza, et al.
Publicado: (2017)

Hepatitis C virus infection characteristics and treatment outcomes in Canadian immigrants
por: Cooper, Curtis L., et al.
Publicado: (2020)

CIHR Canadian HIV Trials Network Co-Infection and Concurrent Diseases Core: Updated Canadian guidelines for the treatment of hepatitis C infection in HIV-hepatitis C coinfected adults
por: Hull, Mark, et al.
Publicado: (2014)

Child Life under Queen Victoria: XII. What Remains to Be Done
Publicado: (1897)

The hurdle with remaining risk for hepatocellular carcinoma in cirrhotic patients after a hepatitis C cure
por: Aleman, Soo
Publicado: (2016)

In the era of rapid mRNA-based vaccines: Why is there no effective hepatitis C virus vaccine yet?
por: Echeverría, Natalia, et al.
Publicado: (2021)

SHARED: An International Collaboration to Unravel Hepatitis C Resistance
por: Howe, Anita Y.M., et al.
Publicado: (2021)

Women in the 2019 hepatitis C cascade of care: findings from the British Columbia Hepatitis Testers cohort study
por: Pearce, Margo E., et al.
Publicado: (2021)

Combination Therapies to Inhibit the RAF/MEK/ERK Pathway in Melanoma: We are not Done Yet
por: McArthur, Grant A.
Publicado: (2015)

Unraveling the Complexity of Liver Disease One Cell at a Time
por: Atif, Jawairia, et al.
Publicado: (2022)

Hepatitis C Seroconversion Remains High among Patients with Regular Hemodialysis: Study of Associated Risk Factors
por: Dharmesti, Ni Wayan Wina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_k87kl0qa9dmec0n01dccji369o